Can Higher Occupancy Help Brookdale Senior Narrow Q2 Losses?

Image Source: Zacks Investment Research

Brookdale Senior missed the consensus estimate for earnings in each of the trailing four quarters, with the average surprise being negative 40%, as you can see below.

Q2 Earnings Whispers for BKD

Our proven model does not conclusively predict an earnings beat for the company this time around as well. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. That’s not the case here.

BKD has an Earnings ESP of 0.00% and carries a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

You can see the complete list of today’s Zacks #1 Rank stocks here.

What’s Shaping BKD’s Q2 Results?

In the second quarter of 2026, BKD witnessed a weighted average occupancy of 82.4%, up from 80.1% a year ago and 82.1% in the first quarter of 2026. It has recorded year-over-year growth in weighted average occupancy in each of the past four quarters. At second-quarter end, the company had the capacity to serve around 46,000 residents in 41 states, with 541 communities.

For the months of April, May and June, same-community weighted average occupancy was at 82.8%, 82.9% and 83%, signaling gradual growth throughout the quarter. Higher occupancy, together with pricing actions, is expected to have lifted second-quarter revenue per available room (RevPAR), supporting improved profitability. Also, it is expected to keep the company on track to deliver RevPAR year-over-year growth of 8-9%.

Furthermore, the company's streamlining initiatives and labor-efficiency efforts are expected to have lowered expenses and narrowed losses.

How Are Other Companies Performing This Quarter?

Companies in the broader Medical space, like Acadia Healthcare Company, Inc. ACHC, The Ensign Group, Inc. ENSG and Universal Health Services, Inc. UHS, have already reported their results for the June quarter, and here’s how they have performed.

Acadia Healthcare reported adjusted second-quarter earnings of 38 cents per share, which beat the Zacks Consensus Estimate by 15.2%. However, the bottom line declined 54% year over year. Strong patient demand, as admissions increased and same-facility patient days improved, supported results. Residential Treatment Facilities also delivered double-digit revenue growth. However, lower revenue per patient day, a shorter average length of stay and higher operating expenses weighed on ACHC’s profitability.

Ensign reported second-quarter 2026 adjusted EPS of $1.92, which beat the Zacks Consensus Estimate by 6.7% and improved 20.8% year over year. ENSG’s strong results were driven by higher occupancy, improved patient days and contributions from acquired and transitioning facilities, along with growth in rental income. The positives were partly offset by higher expenses.

Universal Health Services reported second-quarter 2026 adjusted EPS of $5.98, which beat the Zacks Consensus Estimate by 5.7%. The bottom line rose 10.1% year over year. The strong quarterly results were driven by healthy revenue growth across both the Acute Care and Behavioral Health segments. Higher adjusted admissions, increased patient days and improved unit revenues on a same-facility basis supported performance in both businesses. However, the upside was partly offset by UHS’ elevated operating costs.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research